|

LBL-047 for Injection Clinical Trials

1 actively recruiting trial

Also known as: LBL-047

Pipeline

Phase 1: 1

Top Sponsors

  • Nanjing Leads Biolabs Co.,Ltd1

Indications

  • Systemic Lupus Erythematosus1
  • Lupus1

Other1 trial

A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.